TRANSPHORM INC shareholders Q3 2023

TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 40 filers reported holding TRANSPHORM INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

TRANSPHORM INC shareholders Q3 2023
NameSharesValueWeighting ↓
NEW YORK STATE COMMON RETIREMENT FUND 6,440$140.00%
NISA INVESTMENT ADVISORS, LLC 4,000$8,8800.00%
DEUTSCHE BANK AG\ 780$1,7320.00%
CITIGROUP INC 13$290.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 84,217$186,9620.00%
MORGAN STANLEY 30,775$68,3210.00%
Invesco Ltd. 11,914$26,4490.00%
AMALGAMATED BANK 3,881$90.00%
BlackRock Inc. 1,443,833$3,205,3100.00%
Bank of New York Mellon Corp 85,621$190,0780.00%
NORTHERN TRUST CORP 221,467$491,6560.00%
Tower Research Capital LLC (TRC) 4,931$10,9460.00%
JPMORGAN CHASE & CO 17,523$38,9010.00%
BARCLAYS PLC 5,513$120.00%
ROYAL BANK OF CANADA 3,523$8,0000.00%
VANGUARD GROUP INC 1,464,842$3,251,9490.00%
Ameritas Investment Partners, Inc. 1,608$3,5700.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 6,209$13,7840.00%
UBS Group AG 13,644$30,2890.00%
RHUMBLINE ADVISERS 30,185$67,0030.00%
External links

This page lists TRANSPHORM INC's shareholders in Q3 2023. To view TRANSPHORM INC's shareholder history, click here.